1. Home
  2. BNZI vs COCP Comparison

BNZI vs COCP Comparison

Compare BNZI & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$1.07

Market Cap

15.7M

Sector

N/A

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.03

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
COCP
Founded
2016
2006
Country
United States
United States
Employees
28
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
15.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
BNZI
COCP
Price
$1.07
$1.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$23.00
$6.00
AVG Volume (30 Days)
565.8K
41.7K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.02
EPS
N/A
N/A
Revenue
N/A
$12,712,091.00
Revenue This Year
$185.61
N/A
Revenue Next Year
$32.86
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.86
52 Week High
$4.44
$2.19

Technical Indicators

Market Signals
Indicator
BNZI
COCP
Relative Strength Index (RSI) 47.84 49.97
Support Level $0.92 $1.00
Resistance Level $1.12 $1.11
Average True Range (ATR) 0.07 0.06
MACD 0.00 -0.00
Stochastic Oscillator 79.05 29.63

Price Performance

Historical Comparison
BNZI
COCP

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: